Blog Read the latest perspectives from our team of subject matter experts and others How Incyte Is Advancing Clinical Trial RepresentationClinical trial representation is more than just a regulatory requirement—it’s a critical component of accessible healthcare. Ensuring that trial participants reflect the real-world patient population leads to more effective… Continue reading → Read the article Post Topics:Artificial Intelligence Commercialization Drug Development Global Impact HCP Volunteers KOL Engagement Patient Representation Provider Data Research Post Industries:Commercialization Global Impact Health Plans & Digital Health Pharmaceutical & Biotechnology Provider Data Research KOL EngagementKey Opinion Leader: Dr. Hugh Sampson’s ImpactPublications Scholarly Influence Dr. Hugh Sampson is an esteemed healthcare professional with a specialty in pediatric allergy and immunology. He is the Kurt Hirschhorn Professor of Pediatrics at the… Continue reading → Read the article Drug DevelopmentKOL Engagement9 Ways Medical Affairs Can Use Claims and Referral DataIn a recent interview an experienced medical affairs professional reminisced about the days when key opinion leader selection was a difficult and time consuming activity, which often relied on established… Continue reading → Read the article KOL EngagementProvider DataConnecting the Dots between Patients, Physicians and PayorsSuccessful engagement of external experts ranks very high on the list of challenges medical affairs professionals face. No surprise here, building relationships that support long-term engagement is hard under… Continue reading → Read the article KOL EngagementKey Opinion Leader: Dr. Morie Gertz’s Impact on Hematology & OncologyPublications Scholarly Influence Dr. Morie Gertz is a leading healthcare professional whose specialty is oncology and hematology. Dr. Gertz works at the Mayo Clinic in Minnesota and is the… Continue reading → Read the article KOL EngagementHelpful Hints for MSLsBeginning a new job is exciting, even though new jobs often come with new obstacles and potential challenges. Through the duration of the application process, the prospect of being a… Continue reading → Read the article CommercializationDrug DevelopmentKOL EngagementPatient RepresentationProvider DataResearchH1 Closes $58 Million Series B FundingToday, H1 announced a $58 million Series B round of funding to continue working towards our mission of creating a healthier future by connecting parties in the healthcare ecosystem.… Continue reading → Read the article«‹11121314151617›»
